Found 10 matching trials
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer PHASE1 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Learn More & Join Trial
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer PHASE2 Safety and efficacy of Cardonilmab as a second-line or above treatment in p...
Show More Location
the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Learn More & Join Trial
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma PHASE2 Cadonilimab is a first-in-class bispecific, humanized IgG1 antibody targeti...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases NA This study intends to evaluate the efficacy and safety of cryoablation comb...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus PHASE1 This study is a single-arm, multicenter clinical study to evaluate the effi...
Show More Location
First Affiliated Hospital of Guangxi Medical University
Learn More & Join Trial
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma PHASE2 This is a multicenter, open-label, randomized, controlled clinical study to...
Show More Learn More & Join Trial
Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody PHASE1 In this clinical study, we will evaluate the efficacy and safety of cardoni...
Show More Status
Active Not Recruiting
Location
Zhongshan hospital, Fudan University
Learn More & Join Trial
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer PHASE2 Although unprecedented advances have been made in the field of esophageal c...
Show More Location
Anyang Cancer Hospital
Learn More & Join Trial
Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma. PHASE2 This study is a single-arm, single-center, phase II clinical study. The mai...
Show More Location
Multiple Locations
Learn More & Join Trial
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC NA An assessment of 6-month progression-free survival in patients with mCRC wi...
Show More Location
Huazhong University of Science and Technology
Learn More & Join Trial